NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
NeuroOne Medical Technologies (NASDAQ: NMTC), a medical technology company specializing in neurological disorder surgical care, has announced its upcoming fiscal first quarter 2025 financial results release scheduled for February 12, 2025, before market open.
The company will host an investor conference call and webcast at 8:30 a.m. Eastern time on the same day, featuring management's discussion of Q1 2025 results, a corporate update, and a Q&A session. The earnings call will be accessible via U.S. toll-free (888-506-0062) and international (973-528-0011) dial-in numbers, with participant access code 234314.
A playback will be available until February 26, 2025, through domestic and international replay numbers, using passcode 51728. The webcast replay will be accessible through February 13, 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), un'azienda tecnologica medica specializzata nella cura chirurgica delle malattie neurologiche, ha annunciato il rilascio dei propri risultati finanziari per il primo trimestre fiscale 2025, previsto per il 12 febbraio 2025, prima dell'apertura del mercato.
L'azienda ospiterà una telefonata e webcast per gli investitori alle 8:30, ora dell'Est, lo stesso giorno, con la discussione dei risultati del Q1 2025 da parte della direzione, un aggiornamento aziendale e una sessione di domande e risposte. La telefonata sugli utili sarà accessibile tramite numeri verdi statunitensi (888-506-0062) e internazionali (973-528-0011), con il codice di accesso per i partecipanti 234314.
Un replay sarà disponibile fino al 26 febbraio 2025, attraverso numeri di replay nazionali e internazionali, utilizzando il codice d'accesso 51728. La registrazione del webcast sarà accessibile fino al 13 febbraio 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), una empresa de tecnología médica especializada en el cuidado quirúrgico de trastornos neurológicos, ha anunciado la próxima publicación de resultados financieros del primer trimestre fiscal 2025 programada para el 12 de febrero de 2025, antes de la apertura del mercado.
La empresa llevará a cabo una llamada y webcast para inversionistas a las 8:30 a.m. hora del Este el mismo día, con una discusión por parte de la dirección sobre los resultados del Q1 2025, una actualización corporativa y una sesión de preguntas y respuestas. La llamada de ganancias será accesible a través de números gratuitos en EE. UU. (888-506-0062) y números internacionales (973-528-0011), con el código de acceso para los participantes 234314.
Una reproducción estará disponible hasta el 26 de febrero de 2025, a través de números de reproducción nacionales e internacionales, utilizando el código de acceso 51728. La repetición del webcast estará accesible hasta el 13 de febrero de 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), 신경 장애 수술 치료를 전문으로 하는 의료 기술 회사가 오는 2025 회계년 1분기 재무 결과 발표를 2025년 2월 12일 시장 개장 전 실시한다고 발표했습니다.
회사는 같은 날 동부 시간으로 오전 8시 30분에 투자자 회의 통화 및 웹캐스트를 개최하며, Q1 2025 결과에 대한 경영진의 논의, 기업 업데이트 및 질의응답 세션이 포함됩니다. 수익 통화는 미국의 무료 번호 (888-506-0062) 및 국제 번호 (973-528-0011)를 통해 이용 가능하며, 참가자 접근 코드는 234314입니다.
재생은 2025년 2월 26일까지 제공되며, 국내 및 국제 재생 번호를 통해 51728 패스코드를 사용하여 접근할 수 있습니다. 웹캐스트 재생은 2025년 2월 13일까지 이용 가능합니다.
NeuroOne Medical Technologies (NASDAQ: NMTC), une entreprise de technologie médicale spécialisée dans les soins chirurgicaux des troubles neurologiques, a annoncé la prochaine publication des résultats financiers du premier trimestre fiscal 2025 prévue pour le 12 février 2025, avant l'ouverture du marché.
L'entreprise organisera un appel conférence et webinaire pour les investisseurs à 8h30, heure de l'Est, le même jour, avec une discussion de la direction sur les résultats du Q1 2025, une mise à jour de l'entreprise et une session de questions-réponses. L'appel sur les bénéfices sera accessible via des numéros de téléphone gratuits aux États-Unis (888-506-0062) et internationaux (973-528-0011), avec un code d'accès pour les participants de 234314.
Une rediffusion sera disponible jusqu'au 26 février 2025, via des numéros de rediffusion nationaux et internationaux, en utilisant le code d'accès 51728. La rediffusion du webinaire sera accessible jusqu'au 13 février 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), ein Medizintechnikunternehmen, das auf die chirurgische Behandlung neurologischer Erkrankungen spezialisiert ist, hat die bevorstehende Veröffentlichung der Finanzzahlen für das erste fiskalische Quartal 2025 bekannt gegeben, die für den 12. Februar 2025 vor Markteröffnung geplant ist.
Das Unternehmen wird am selben Tag um 8:30 Uhr Eastern Time eine Investorentelefonkonferenz und ein Webcast veranstalten, in dem die Geschäftsführung die Ergebnisse des Q1 2025 erörtern, ein Unternehmensupdate geben und eine Frage-Antwort-Runde durchführen wird. Die Gewinnkonferenz ist über die gebührenfreien US-Nummern (888-506-0062) und internationale Nummern (973-528-0011) mit dem Zugangscode 234314 erreichbar.
Eine Wiederholung wird bis zum 26. Februar 2025 über nationale und internationale Wiederholungsnummern verfügbar sein, mit dem Zugangscode 51728. Die Webcast-Wiederholung wird bis zum 13. Februar 2025 zugänglich sein.
- None.
- None.
EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal first quarter ended December 31, 2024, before market open on February 12, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. eastern time on Wednesday, February 12, 2025, to discuss the Company’s first quarter 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
First Quarter and Fiscal 2025 Earnings Conference Call
Date: Wednesday, February 12, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 234314
Webcast: https://www.webcaster4.com/Webcast/Page/2821/52002
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through Wednesday, February 26, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 51728. A webcast replay will also be available using the webcast link above through February 13, 2025.
About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us
FAQ
When will NeuroOne (NMTC) release its Q1 2025 financial results?
What time is NeuroOne's (NMTC) Q1 2025 earnings conference call?
How can investors access NeuroOne's (NMTC) Q1 2025 earnings call?
Until when will the replay of NeuroOne's (NMTC) Q1 2025 earnings call be available?
